Intercept Pharmaceuticals (ICPT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select FieldsSymbol | ICPT | RGNX | ETNB | ||
Company | Intercept Pharmaceuticals | Regenxbio Inc | 89Bio Inc | ||
Price Information | |||||
Exchange | NASDAQ | NASDAQ | NASDAQ | ||
Open | 19.00 | 16.20 | 8.32 | ||
High | 19.01 | 16.45 | 8.45 | ||
Low | 18.98 | 15.72 | 8.18 | ||
Last | 19.00 | 16.19 | 8.26 | ||
Change | +0.04 | +0.13 | +0.01 | ||
% Change | +0.21% | +0.81% | +0.12% | ||
Volume | 3,963,400 | 305,600 | 653,000 | ||
20-Day Average Volume | 1,984,495 | 457,585 | 779,195 | ||
Previous Close | 18.96 | 16.06 | 8.25 | ||
Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
Has Options | No | Yes | Yes | ||
Technicals | |||||
20-Day Moving Average | 18.81 | 17.94 | 9.75 | ||
20-Day Raw Stochastic | 99.00% | 15.81% | 6.22% | ||
20-Day Relative Strength | 74.51% | 36.67% | 33.77% | ||
Weighted Alpha | -13.30 | -29.55 | -25.70 | ||
Today's Opinion | 88% Buy | 24% Sell | 72% Sell | ||
Previous Opinion | 88% Buy | 8% Sell | 72% Sell | ||
Last Month's Opinion | 56% Buy | 88% Buy | 8% Buy | ||
Performance | |||||
5-Days | |||||
%Chg | +0.37% since 10/31/23 | +3.19% since 04/19/24 | -9.03% since 04/19/24 | ||
Low | 18.93 on 11/02/23 | 15.18 on 04/22/24 | 8.04 on 04/25/24 | ||
High | 19.02 on 11/06/23 | 16.66 on 04/24/24 | 9.78 on 04/22/24 | ||
1-Month | |||||
%Chg | +2.15% since 10/06/23 | -25.29% since 03/26/24 | -26.25% since 03/26/24 | ||
Low | 17.01 on 10/13/23 | 15.18 on 04/22/24 | 8.04 on 04/25/24 | ||
High | 19.02 on 11/06/23 | 22.42 on 03/28/24 | 11.69 on 03/28/24 | ||
3-Month | |||||
%Chg | +82.87% since 08/07/23 | +27.28% since 01/26/24 | -18.78% since 01/26/24 | ||
Low | 9.70 on 08/14/23 | 11.83 on 02/02/24 | 7.47 on 02/06/24 | ||
High | 19.02 on 11/06/23 | 28.80 on 03/05/24 | 16.63 on 03/04/24 | ||
6-Month | |||||
%Chg | +17.57% since 05/05/23 | +5.47% since 10/26/23 | +20.23% since 10/26/23 | ||
Low | 8.82 on 05/24/23 | 11.83 on 02/02/24 | 6.60 on 10/27/23 | ||
High | 19.02 on 11/06/23 | 28.80 on 03/05/24 | 16.63 on 03/04/24 | ||
Key Statistics | |||||
Market Capitalization, $K | 793,877 | 794,006 | 786,558 | ||
Shares Outstanding, K | 41,783 | 49,043 | 95,225 | ||
Annual Sales | 285,710,000 | 90,240,000 | 0 | ||
Annual Net Income | 221,820,000 | -263,490,000 | -142,190,000 | ||
Last Quarter Sales | 83,720,000 | 22,210,000 | 0 | ||
Last Quarter Net Income | -5,860,000 | -62,890,000 | -40,240,000 | ||
60-Month Beta | 0.88 | 1.29 | 1.04 | ||
Per-Share Information | |||||
Most Recent Earnings | -0.07 on 11/06/23 | -1.43 on 02/27/24 | -0.50 on 02/29/24 | ||
Latest Earnings Date | 11/07/23 | 05/01/24 | 05/02/24 | ||
Most Recent Dividend | N/A | N/A | N/A | ||
Next Ex-Dividends Date | N/A | N/A | N/A | ||
Ratios | |||||
Price/Earnings ttm | 0.00 | 0.00 | 0.00 |